Home / Business and Economy / Billionaire Family Office Invests $65M in HeartFlow

Billionaire Family Office Invests $65M in HeartFlow

Summary

  • Schusterman Interests acquired 1.9 million HeartFlow shares.
  • The new stake is valued at $65.3 million as of September 30.
  • HeartFlow shares surged 70% above their August IPO price.
Billionaire Family Office Invests $65M in HeartFlow

Schusterman Interests, a prominent family office based in Tulsa, has revealed a new substantial investment in HeartFlow, Inc. The firm acquired more than 1.9 million shares of the healthcare technology company during the third quarter, with the stake valued at $65.3 million as of September 30. This strategic move positions HeartFlow as the fourth-largest holding within Schusterman Interests' portfolio.

HeartFlow, a company focused on non-invasive diagnostic tools for coronary artery disease leveraging AI, has experienced significant market traction since its August IPO. The company's shares have reportedly surged approximately 70% above their initial offering price of $19. This impressive growth trajectory following its upsized offering, which raised over $316 million, highlights investor confidence in its technology.

The investment from Schusterman Interests, backed by the Charles and Lynn Schusterman Family Investments, signals a strong vote of confidence in HeartFlow's innovative AI-powered platform. This development is particularly notable given the current volatility in early-stage medtech valuations, suggesting a long-term belief in HeartFlow's potential for durable revenue growth.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Schusterman Interests acquired over 1.9 million shares of HeartFlow, Inc. valued at $65.3 million, making it their fourth-largest holding.
HeartFlow's stock has risen approximately 70% above its August IPO price of $19.
HeartFlow is a healthcare technology company specializing in advanced, non-invasive diagnostic tools for coronary artery disease using AI.

Read more news on